New Therapeutic Approaches for the Treatment of Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and Increased Cardiovascular Risk

Metabolic dysfunction-associated steatotic liver disease (MASLD) was previously known as nonalcoholic fatty liver disease (NAFLD). The main characteristic of the disease is the process of long-term liver inflammation, which leads to hepatocyte damage followed by liver fibrosis and eventually cirrhos...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Marija Branković, Marija Dukić, Tijana Gmizić, Višeslav Popadić, Novica Nikolić, Ana Sekulić, Milica Brajković, Jelena Đokić, Edvin Mahmutović, Ratko Lasica, Marko Vojnović, Tamara Milovanović
Format:	Artigo
Jezik:	Inglês
Izdano:	MDPI AG 2024-01-01
Serija:	Diagnostics
Teme:	MASLD cardiovascular diseases metabolic syndrome pharmacotherapy
Online dostop:	https://www.mdpi.com/2075-4418/14/2/229
Oznake:	Označite Brez oznak, prvi označite!